Outlook Therapeutics Inc.
(OTLK) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
2.38
-0.21%
After-hours Jan 06, 2025, 07:50 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
Cash & Equivalents | 14.93M | 23.39M | 17.40M | 14.48M | 12.54M | 8.02M | 1.72M | 3.19M | 2.35M | 2.35M | 9.07M |
Short-Term Investments | 14,927.50B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 793.93K | 804.93K | 853.66K | 900.00K | n/a | n/a | n/a | 216.09K | n/a | n/a |
Other Long-Term Assets | 1,132.50B | 501.30K | 132.01K | 174.59K | 394.45K | 457.48K | 491.04K | 740.36K | 852.80K | 447.55K | 2.08M |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.30M | 4.30M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -20 | n/a |
Other Current Assets | 12,488.50B | 7.59M | 10.12M | 7.03M | 4.61M | 5.49M | 1.19M | 199.74K | 1.35M | 1.79M | 1.79M |
Total Current Assets | 27,416.00B | 30.98M | 27.52M | 21.51M | 17.94M | 13.50M | 3.30M | 3.90M | 5.68M | 3.15M | 15.16M |
Property-Plant & Equipment | 274.64B | 26.17K | 70.36K | 275.05K | 494.24K | 3.18M | 18.49M | 16.09M | 16.96M | 8.01M | 17.76M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 1,407.10B | 1.32M | 1.01M | 1.30M | 1.79M | 3.63M | 18.98M | 16.83M | 18.03M | 8.46M | 19.84M |
Total Assets | 28,823.20B | 32.30M | 28.53M | 22.81M | 19.73M | 17.13M | 22.28M | 20.73M | 23.71M | 11.60M | 35.01M |
Account Payables | 7.97M | 6.57M | 3.49M | 2.20M | 2.39M | 2.28M | 3.61M | 10.95M | 5.07M | 11.56M | 11.56M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 1.74M | 3.09M | 1.21M | 1.50M | 1.98M |
Short-Term Debt | 29.49M | 35.56M | 10.95M | 973.52K | 7.85M | 11.53M | 18.38M | 5.01M | 6.18M | 15.82M | 15.82M |
Other Current Liabilities | 42,553.70B | 2.75M | 3.43M | 1.73M | 3.79M | 4.62M | 6.46M | 7.34M | 6.12M | -8.74M | 5.92M |
Total Current Liabilities | 42,553.70B | 46.73M | 19.73M | 6.75M | 15.89M | 20.29M | 32.04M | 28.74M | 20.44M | 20.21M | 37.04M |
Long-Term Debt | 246.92K | n/a | 4.27K | 10.93M | 946.68K | 3.42M | 3.55M | 13.41M | 2.55M | 6.14M | 6.14M |
Other Long-Term Liabilities | 59,345.90B | 6.22K | 57.14K | 522.92K | 71.32K | 4.20M | 4.74M | 4.84M | 761.33K | 2.43M | 284.71K |
Total Long-Term Liabilities | 59,345.90B | 6.22K | 61.41K | 11.45M | 1.02M | 7.61M | 11.05M | 22.72M | 8.47M | 14.94M | 27.22M |
Total Liabilities | 101,899.70B | 46.74M | 19.79M | 18.20M | 16.91M | 27.90M | 43.09M | 51.46M | 28.91M | 35.15M | 64.26M |
Total Debt | 29.74M | 35.56M | 10.96M | 11.90M | 8.80M | 14.95M | 21.93M | 18.42M | 8.73M | 15.17M | 21.96M |
Common Stock | 239.06K | 2.60M | 2.27M | 1.76M | 1.27M | 286.10K | 722.20K | 249.34K | 228.03K | 39.84K | 39.84M |
Retained Earnings | -543,284.90B | -467.92M | -408.94M | -342.88M | -289.72M | -254.48M | -216.31M | -186.22M | -147.39M | -45.15M | -94.06M |
Comprehensive Income | n/a | n/a | 417.67M | -22,811.50B | -19,732.60B | 238.35M | 190.76M | -8.64M | -5.96M | -1.82M | -3.64M |
Shareholders Equity | -73,076.50B | -14.44M | 8.74M | 4.61M | 2.83M | -10.77M | -20.81M | -30.73M | -5.20M | -23.55M | -28.60M |
Total Investments | 693.19K | 793.93K | 804.93K | 853.66K | 900.00K | n/a | n/a | n/a | 216.09K | n/a | n/a |